Applied Filters
Womble Bond Dickinson boosts IP arm with patent expert
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department.
Bio-Techne takes patent dispute to UK
The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.
EMA backs switch to biosimilars
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.
US company secures genetically modified rice ban against Chinese rival
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.
Texas court awards $41m to US biotech
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.
Haynes Boone hires top biotech patent lawyer
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office.
BMS petitions SCOTUS to revive $1.2bn win
BMS unit Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have urged the US Supreme Court to reinstate their $1.2 billion win in a patent clash with Kite Pharma, a subsidiary of Gilead.
Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent
The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.
Queen’s speech trails gene-editing innovation bill
The UK government will implement the Genetic Technology Bill which promises to “remove unnecessary barriers” inherited from the European Union to bolster gene-editing technology.
L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences
Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.
